In summary, we show that the aggressive clones derived from CD49f+/CD44+/CD24− single cells activate the OCT4/SOX2/lincRNA-RoR signaling axis to maintain cancer stem cell self-renewal and regulate differentiation. The gene discussed is CD44; the disease is cancer.